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GENERAL INTRODUCTION 
Glutathione synthetase (EC 6.3.2.3, y-L-glutamyl-L-cysteine : glycine li-
gase(ADP-fonning)) catalyzes the synthesis of glutathione from y-Glu-
Cys and Gly in the presence of ATP (1,2). Namely, this enzyme catalyzes 
the second reaction in the glutathione biosynthetic pathway in which 
firstly y-Glu-Cys is synthesized by y-glutamylcysteine synthetase (EC 
6.3.2.2, L-glutamate : L-cysteine y-ligase(ADP-fonning)) (3,4). 
Glutathione synthetase is distributed in a wide variety of sources 
(I,2). Highly purified enzyme preparations have been obtained from 
yeast (5), rat kidney (6), and Escherichia coli B (7). Molecular weight of 
these enzymes are determined as 12,3000 for the yeast, 118,000 for the rat 
kidney, and 142,000 for the E. coli B preparations. An optimum pH of 
the enzyme is 8.0 - 8.5. 
The substrate speCificity of rat kidney glutathione synthetase has 
been examined in terms of the acceptability of y-Glu-Cys and Gly deriva-
tives (6). Since the amino acid moiety of y-glutamyl-amino acids was lim-
ited to those sterically similar to cysteine (e.g., a-aminobutyrate, serine, 
alanine), the rat kidney enzyme is highly specific toward the cysteine 
moiety of y-Glu-Cys. The D-y-glutamyl derivatives and N-methyl, a-
methyl, ~-methyl, and y-methyl-L-a-glutamyl derivatives of L-y-glu-
tamyl-L-a-aminobutyrate were significantly active substrates. Moreover, 
N -acetyl-L-cysteine is also active. The L-y-glutamyl moiety of L-y-glu-
tamyl-L-a-aminobutyrate can be modified considerably with retention of 
substrate activity. Three possible monomethyl derivatives of Gly ( L-Ala, 
D-Ala, and sarcosine) are not active, nor is glycinamide. However, sub-
stantial activity is found with aminooxyacetate (NH20CH 2COOH) and N-
hydroxyglycine. Moore and Meister indicated that the substrate speci-
ficity of the E. coli B enzyme was probably similar to that of the rat kid-
ney enzyme (8). 
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( I ) 
FIG. 0-1. Scheme of the reaction catalyzed by glutathione synthetase. 
Reaction catalyzed by glutathione synthetase is supposed to proceed 
via enzyme-bound acylphosphate as an intermediate like those of glu-
tamine synthetase and y-glutamyIcysteine synthetase 0). As the evidence 
for the formation such a acyl phosphate, y-glutamyl-a-aminobutyryl 
phosphate has been first obtained by using pulse-labeling technique (9.10) 
in the synthesis of y-glutamyl-a-aminobutyrylglycine(ophthalmic acid) 
with glutathione synthetase. According to this model, the reaction 
proceeds in a following scheme (Fig. 0-1). The enzyme combines A TP 
and y-Glu-Cys in the presence of Mg++ to yield a complex (I) ; phospho-
rylation of the y-Glu-Cys yields complex (II), which consists of enzyme, 
ADP, Mg++, and the y-glutamylcysteinylphosphate. Subsequently, com-
plex (II) can react with glycine to yield complex (m) and orthophosphate, 
from which GSH and ADP dissociate. In contrast, Wendel and Flohe 
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proposed another model by kinetic studies on purified bovine erythrocyte 
glutathione synthetase (11). Glutathione synthetase is first activated by 
ATP and Mg++, then reacts with y-Glu-Cys and Gly, randomly, to form 
the enzyme-three substrates complex (they called central complex), from 
which products, GSH, ADP and orthophosphate are released consecu-
tively. In the latter model, complex (I), (II), and (III) in Fig. 0-1 are not 
distinguishable, thus the Gly binding and orthophosphate release are not 
ordered. Nevertheless, their kinetic data is not enough to exclude the 
scheme in Fig. 0-1. 
In contrast to the information about the overall aspects of the cat-
alytic pathway of glutathione synthetase reaction, the following informa-
tions remain unclear such as the binding property of substrates, particu-
larly interactions of amino acid residues of the enzyme with substrates, 
and protein structures of the enzyme. 
Involvement of cysteine residues in the catalytic function of glu-
tathione synthetase has been suggested from chemical modification using 
sulfhydryl reagents. In the rat kidney enzyme, p-chloromercuribenzoate 
(pCMB) showed a marked inhibition, but N-ethylmaleimide and 5,5'-
dithiobis(2-nitrobenzoate) had no effect on catalytic activity (6). In the E. 
coli B enzyme, pCMB was also a potent inhibitor (7). Although, many 
details of the role of cysteine residues remain to be learned. 
Therefore, precise knowledge for the reaction mechanism, in par-
ticular for the structure-function relationship is not yet available. 
Recently, enzymology has been evolved and transformed by X-ray 
crystallography, genetic engineering, and computer technology (I 2). 
Protein engineering (I 3) is realized by those technology. However, the 
technology to do is already available but lack of prinCiples of the protein 
design is a serious constraint in protein engineering. 
In the present study, this author applied protein engineering tech-
niques to examine the structure and function of glutathione synthetase 
from E. coli B, and come up with the principle of molecular design of 
protein. Primary structure of glutathione synthetase has been determined 
only for the enzyme from E. coli B by N-terminal amino acid sequence 
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analysis and by DNA sequence analysis of the gsh II gene (14). The E. 
coli B enzyme is a tetrarner of identical subunit of 35,600 dalton (7). 
Each subunit of the E. coli B enzyme is composed of316 amino acids in-
cluding four cysteines. In Chapter I, Property of the ATP binding site 
was investigated by use of amino acid sequence homology (similarity). 
This approach is related to find out a module or motif structures partici-
pated in substrate binding. In Chapter 11, the glutathione synthetase gene, 
gsh II was subcloned into overexpression plasmid, thus overproduction 
and rapid purification of the enzyme are achieved. In Chapter III, role of 
cysteine residues was analyzed by using chemical modification and site-
directed mutagenesis. In Chapter IV, the E. coli B glutathione synthetase 
was crystallized and preliminary X-ray crystallographic studies were 
investigated. In addition, small angle X-ray scattering was measured 
about solution of the enzyme to compare in the aqueous solution state. 
CHAPTER I 
Similarity of Escherichia coli B Glutathione 
Synthetase with Dihydrofolate Reductase 
in Amino Acid Sequence and 
Substrate Binding Site. 
I -1 INTRODUCTION 
In order to find which amino acids of glutathione synthetase construct a 
substrate binding site and contribute to its catalytic reaction, the author 
compared the amino acid sequence of the Escherichia coli B glutathione 
synthetase with those of other enzymes. The amino acid sequence of glu-
tathione synthetase is less similar with glutamine synthetase, glutathione 
reductase and ATPase. Amino acid sequence similarity search against a 
protein sequence database, however, revealed that the amino acid se-
quence of the E. coli B glutathione synthetase from Arg-55 to Ile-96 were 
highly similar to that of mouse dihydrofolate reductase from Gln-47 to 
Leu-89. In addition, the amino acid sequence of glutathione synthetase 
was locally similar to those of other bacterial and mammalian dihydrofo-
late reductases with a span of 40 residues (Fig. 1-1), although glutathione 
synthetase and dihydrofolate reductase are quite different enzymes not 
only in their catalytic mechanisms, amide synthesis and hydrogenation, 
but also in their substrate requirements, y-Glu-Cys, Gly and 7,8-dihydro-
folate, respectively. 
On the basis of these findings, the author tried to identify a func-
tional role of the similar portion of the amino acid sequence in the E. coli 
B glutathione synthetase. First, the author improved a procedure of the 
purification of the E. coli B glutathione synthetase and obtained the en-
zyme preparation with a higher specific activity than those reported in 
other papers. With this enzyme preparation, the author found that the 
5 
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FIG. I-I. Amino acid alignment of the E. coli B glutathione synthetase 
with dihydrofolate reductase from ten origins with a span of 40 
residues. Score is the measure of similarity based on the amino acid mutation data 
(Ref. 26). The values shown are the minimum value of each pair of sequences. 
E. coli B glutathione synthetase was potently inhibited not only by spe-
cific inhibitors of dihydrofolate reductase such as methotrexate (MTX) 
and trimethoprim, but also by its substrate 7,8-dihydrofolate. In particu-
lar, the inhibition by MTX was examined in detail, whereby it was proved 
that glutathione synthetase has an ATP binding site similar to a substrate 
binding site of dihydrofolate reductase. Then, the author analyzed 1) the 
folding of the similar portion of the polypeptide chain in the crystal 
structure of Lactobacillus casei dihydrofolate reductase and 2) the 
boundary of the similarity in the amino acid sequence with respect to the 
intron-exon boundary in mammalian dihydrofolate reductase genes. 
These analyses revealed that the similar portion of the polypeptide chain 
folds to make a structurally and genetically distinct subdomain; that is, this 
subdomain functions as a NADPH binding site in dihydrofolate reductase 
and as an ATP binding site in the E. coli B glutathione synthetase. 
Therefore, this study gives an experimental evidence that local similarity 
in amino acid sequences conserves a functional similarity even in enzymes 
having different catalytic mechanisms. 
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1-2 EXPERIMENTAL PROCEDURES 
Chemicals ATP, NADPH, and yeast glutathione reductase were pur-
chased from Oriental Yeast (Osaka). 7,8-Dihydrofolate, methotrexate, 
and trimethoprim were from Sigma (St. Louis). y-Glu-Cys was supplied 
by Kojin. DEAE-cellulose, Butyl-toyopearl 650M, Hydroxyapatite, 
Cellulofme GCL-2000 sf were supplied by Brown (Berlin), Toyo soda, 
Wako Chemical (Osaka), Chisso (Minamata), respectively. All other 
chemicals were the purest grades commercially available. 
Bacterial Strain and Cultivation The gene for glutathione 
synthetase of E. coli B has been cloned onto vector plasmid pBR325 (15). 
E. coli C600 cells transformed by a recombinant plasmid pBR325 were 
grown on a nutrient medium (16) containing 0.005% Ampicillin at 30°C 
for 20 h with reciprocal shaking. 
Determination of Enzyme Activity The activity of glutathione 
synthetase was determined at 37°C and pH 7.5. The enzyme solution, 5JlI, 
was added to an assay medium composed of 5 mM y-Glu-Cys, 10 mM Gly, 
10 mM ATP, 10 mM MgS04, and 100 mM Tris-HCl buffer (pH 7.5) in a 
total volume of O. 1 ml. To terminate the reaction, a test tube containing 
the reaction mixture was immersed in boiling water for 2 min. Glu-
tathione was determined as the amount of 2-nitro-5-thiobenzoic acid 
which was formed by thiolysis of 5,5'-dithiobis-(2-nitrobenzoic acid) 
with glutathione in the presence of NADPH and glutathione reductase 
(I 7). One unit of enzyme was defined as the amount that catalyzed the 
fonnation of 1 Ilmol of glutathione per min at 37°C and pH 7.5. 
Dihydrofolate reductase-like activity of glutathione synthetase was 
determined spectrophotometrically at 25 DC as the decrease in absorption 
ofNADPH at 340nm (I8). The assay system contained 77IJM 7,8-dihy-
drofolate, 77 11M NADPH, 7.7 mM 2-mercaptoethanol, and 39 mM potas-
sium phosphate buffer (pH 7.5) in a total volume of 1.3 ml. Enzyme 
solution 50 j.d was added to initiate the reaction. 
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Protein determina lion Protein was determined by the method of 
Lowry (19). The concentration of glutathione synthetase in the purified 
preparation was calculated from the absorption coefficient A~~= 9.02 ± 
0.44 that was experimentally determined at 280 nm in 0.05 M potassium 
phosphate buffer pH 7.0 by the dry weight method (20). 
Purification of Glutathione Synthetase All procedures were 
carried out at a -4°C, unless otherwise stated. 
Step 1. Preparation of crude extract The cells (I 56 g in wet 
weight) from 15 liters of culture were suspended in 500 ml of 10 mM 
Tris-HCI buffer (pH 7.2), and disrupted for 1 min x 3 with Dyno-Mill at 0 
DC. Cell debris was removed by centrifugation at 10,000 x g for 15 min. 
Step 2. DEAE-cellulose column chromatography Crude extract 
(660 ml, 6.9 g protein) was applied to a DEAE-cellulose column (6 x 51 
em) equilibrated with 10 mM tris-Hel buffer (pH 7.2) and eluted from the 
column with a linear gradient established between the tris-HC! buffer and 
the same buffer containing 1.0 M KCI. Enzyme activity was eluted at a 
KCI concentration of approximately 0.2 M. The active fractions, 910 ml, 
were collected and added to 430 g of solid (NH4)2S04 (70% saturation). 
After stirring for 1 h, the precipitate was collected by centrifugation at 
10,000 x g for 20 min, dissolved in 100 ml of 50 mM potassium phosphate 
buffer (pH 7.0), then dialyzed against 5 liters of the buffer for 15 h. 
Step 3. Butyl-Toyopearl 650M column chromatography The en-
zyme solution (122 m]) from step 2 was added to 21.5 g of solid 
(NH 4)2S04 (30 % saturation) and stirred for) h. The precipitate was 
removed by centrifugation at 10,000 x g for 15 min, and supernatant (ISO 
m]) was applied to a Butyl-Toyopearl 650M column (5 x 35 cm) pre-
equilibrated with 50 mM potassium phosphate buffer containing 1.33 M 
(NH4)2S04 (pH 7.0). The column was washed with 2 liters of the same 
buffer. Elution was carried out with linear concentration gradient of 
(N~hS04 decreasing from 1.33 to a M. The active fractions, 280 mI, 
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were eluted at a (NH4)2S04 concentration of apprQximately 0.83 M and 
concentrated to about 5 mi on a Amicon UM~10 membrane. 
Step 4. Celluiofine GCL~2000 column chromatography The en-
zyme solution from step 3 was applied to a Cellulofine GCL-2000 sf 
column (3 x 127 em) pre-equilibrated with 50 mM potassium phosphate 
buffer containing 0.1 M KCl and 5 mM MgCh. Elution was carried out 
with the same buffer. The active fractions, 18.4 mI, were pooled and dia-
lyzed against 5 liters of 2.5 mM potassium phosphate buffer (pH 6.8). 
Step 5. Hydroxyapatite column chromatography The dialyzate (25 
m]) was applied to a hydroxyapatite column (2 x 30 em) equilibrated with 
2.5 mM potassium phosphate buffer (pH 6.8). Elution was carried out 
with a linear concentration gradient of potassium phosphate buffer from 
2.5 to 100 mM. Active fractions, 59 mI, were eluted at approximately 60 
mM potassium phosphate and concentrated to 2 ml on an Amicon UM -10 
membrane. The enzyme preparations thus obtained was stored at -20 DC 
and used as the source of glutathione synthetase throughout this study. 
Electrophoresis SDS-po]yacrylamide gel electrophoresis was per-
formed on 10 % acrylamide by the method of Laemmli (21). Proteins 
were detected by staining with Coomassie brilliant blue R-250. 
Reaction of Glutathione Synthetase with Inhibitors The 
enzyme solution was pre-incubated with an inhibitor at 37 DC for 10 min, 
then it was added into the assay mixture for glutathione synthetase. The 
mixture contains the inhibitor at the same concentration to the pre-
incubation reaction. 
Kinetic Data Analysis Apparent Km and Vrnax values were 
determined by the non-linear least squares fitting method (22). The values 
for ATP were determined by the double-reciprocal plot because substrate 
inhibition by ATP appeared at higher concentrations. 
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Similarity Search in Amino Acid Sequences Local similarity 
in the amino acid sequence of the E. coli B glutathione synthetase was 
searched against a database, DDB], compiled by T. Ooi and H. Nakashima 
(Institute for Chemical Research, Kyoto University) (23). This database 
contains 3050 amino acid sequences of various types of proteins. Our 
search was limited to 1186 sequences relating to 280 different kinds of 
enzymes. A procedure which finds within longer sequences all subse-
quences that locally resemble one another was based on an algorithm de-
veloped by Goad and Kanehisa (24, 25). The measure of similarity is 
based on an amino acid mutation data (PAM matrix) among related pro-
teins (26). Weight for a deletion was set equal to 8. 
1-3 RESULTS 
Purification of Glutathione Synthetase Table I-I summarizes 
purification of the E. coli B glutathione synthetase from IS-liter culture 
TABLE I-I 
Purification of Glutathione Synthetase: Summary. 
Total Specific Total 
Recovery Purity 
protein activity activity 
(mg) (unitlVmg) (unita) (%) ( -fold) 
Crude extract 6,860 0.385 2,640 100 
DEAE-cellulose 1,640 2.51 4,120 156 7 
Buty1-Toyopearl 168 12.3 2,070 78.4 32 
Cellulofine 50.9 27.3 1,390 52.7 71 
GeL-2000 sf 
Hydroxyapatite 14.8 42.8 633 24.0 III 
a One unit of enzyme was defined as the amount producing 1 J.lmole ofGSH per min 
under standard assay condition. 
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of E. coli C600. Overall purification achieved was approximately 110-
fold with 24 % yield of the crude extract in the activity. Purified prepa-
rations gave a single band on the SDS-polyacrylamide gel electrophoresis 
and exhibited a constant specific activity, 42.8 uniUmg protein, which is a 
three- to six-fold activity of those reported previously (5, 6, 7). 
Purification of the E. coli B glutathione synthetase took eight steps 
in the previous report (7). Butyl-Toyopearl 650M column chromatogra-
phy in the present study reduced the steps required for purification and 
improved both the specific activity and recovery of the enzyme. Enzyme 
preparations from rat kidney have been effectively purified by affinity 
chromatography on Agarose-aminohexyl-N6-ATP (2, 6). But the E. coli 
B enzyme failed to be adsorbed on Agarose-aminohexyl-N6-ATP. This is 
due to the weak binding of ATP to the E. coli B enzyme when compared 
with the rat kidney enzyme. The apparent Km values of ATP were 1.85 
mM for the E. coli B enzyme (see Table I-ill), but 0.03 mM for the rat 
kidney enzyme (6). 
No activity as dihydrofolate reductase was observed with the E. coli 
B enzyme preparation. 
Inhibition of Glutathione Synthetase by Ligands of Dihydro-
folate Reductase The purified preparation of the E. coli B glu-
tathione synthetase was effectively inhibited by 7,8-dihydrofolate, MTX, 
and trimethoprim (Table I-II). While 7,8-dihydrofolate is a substrate of 
dihydrofolate reductase, MTX and trimethoprim are its inhibitors. 
Stone and Morrison (27) recently reported that trimethoprim was 
different from MTX in the inhibition potency to bacterial and avian dihy-
drofolate reductases: MTX inhibits chicken liver as well as E. coli dihy-
drofolate reductases, inhibition constant K j = 1.3 and 3.6 nM, respec-
tively. Trimethoprim, however, inhibits the chicken liver dihydrofolate 
reductase less than the E. coli dihydrofolate reductase by a 5000-fold, 
K j = 3530 and 0.49 nM, respectively. In this experiment, the E. coli B 
glutathione synthetase was inhibited more potent by MTX than by 
trimethoprim. Such difference in their inhibiting activities between MTX 
and trimethoprim could be ascribed to the fact that the amino acid 
sequence of the E. coli B glutathione synthetase is more homologous to 
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TABLE I-II 
Effect of Ligands for Dihydrofolate Reductase on Glutathione Synthetase Activity 
Glutathione synthetase was pre-incubated with the respective concentration of 
each ligand for dihydrofolate reductase in 100 mM Tris-HCl buffer (pH 7.5) at 3rC 
for 10 min, then the enzyme solution was added in to the assay mixture for glutathione 
synthetase,S mM y-Glu-Cys,15 mM Gly,IO mM ATP,IO mM MgS04 , and 100 mM 
Tris-HCI buffer (pH 7.5) containing the ligand at the same concentration as in the pre-
incubation reaction. 
Ligands Conc Relative activity 
(mM) (%) 
Control 100 
MTX 0.01 75.0 (8.59)a 
0.1 36.0 (7.83) 
Dihydrofolate 0.1 53.90.82) 
Trimethoprim 0.1 82.9 (2.22) 
0.3 58.2 (0.28) 
NADPH 2.0 98.0 (0.85) 
a Values in parentheses are standard error. 
the mammalian dihydrofolate reductases than to the bacterial dihydrofo-
late reductases. 
Cofactor NADPH, however, showed little inhibitory activity to 
glutathione synthetase. 
Mechanism of Inhibition of Glutathione Synthetase by 
Methotrexate Inhibition of the E. coJi B glutathione synthetase by 
MTX was analyzed according to the method developed by Cleland (28, 
29). Concentrations of ATP and MTX were varied under the fixed con-
centration of y-Glu-Cys and Gly at 15 mM. 
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FIG. 1-2. Double-reciprocal plots for MTX inhibition with respect to 
ATP. The assay mixture contained 15 mM y-Glu-Cys, 15 mM Gly, 10 mM MgS04, 
100 mM Tris-HCI buffer (pH 7.5), and varied concentration of ATP. MTX concentra-
tions arc 0 (e) ,0. I mM (0), and 0.3 mM (0). Insert: Secondary plot for slope of 
double-reciprocal plots versus MTX concentration. 
Although substrate inhibition by ATP appeared at the concentrations of 
ATP higher than about 15 mM, double-reciprocal plot l/v vs l/[ATP] 
gave a family of lines that converged on the l/y axis (Fig. 1-2). This plot 
shows that the inhibition of glutathione synthetase by MTX is competitive 
with respect to ATP. When concentrations of y-Glu-Cys and MTX were 
varied under the fixed ATP and Gly concentration, lines in double-recip-
rocal plot l/v vs lI[y-Glu-Cys] converged on the 1I[ y-Glu-eys] axis (Fig. 
1-3). From this plot, it is shown that inhibition by MTX is noncompetitive 
with respect to y-Glu-Cys. When glutathione synthetase was inhibited by 
MTX in the presence of Gly as the varied substrate, parallel lines was 
obtained in double-reciprocal plot l/v vs I/[Gly J (Fig. 1-4). Therefore, 
inhibition by MTX is uncompetitive with respect to Gly. The values of 
inhibition constant K j of MTX with respect to ATP, y-Glu-Cys, and Gly 
are summarized in Table III with their apparent Km values. The K j values 
of MTX are almost constant, 0.1 mM, independent of a substrate varied 
and are 20 - 50 times smaller than Km values of ATP, y-Glu-Cys, and Gly. 














FIG. 1-3. Double-reciprocal plots for MTX inhibition with respect to y-
Glu-Cys. The assay mixture contained 10 mM ATP, 15 mM Gly, 10 mM MgS04, 
100 mM Tris-HCl buffer (pH 7.5), and varied concentration ofy-Glu-Cys. MTX con-
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FIG. 1-4. Double-reciprocal plots for MTX inhibition with respect to Gly. 
The assay mixture contained 10 mM ATP, 15 mM y-Glu-Cys, 10 mM MgS0 4 , 100 
mM tris-HCl buffer (pH 7.5), and varied concentrations of Gly. MTX concentrations 
are 0 (e) and 0.1 mM (0). 
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TABLE I-Ill. 
The Values ofInhibition Constant ~ and Inhibition Type ofMTX with respect to 
ATP, y·Glu- Cys, and Gly with Their Apparent Km Values. 
Km(mM) K/mM) 
ATP 1.85(0.39)b 0.10(0.01) 
y-Glu-Cys 3.33(0.37) 0.07(0.04) 
Gly 3.53(0.70) 0.10(0.02) 
aInhibition types were determined from Fig. 1-2, 1-3, and 1-4. 






Meister analyzed reactions of glutathione synthetase and proposed that the 
reaction proceeded by the ordered mechanism containing three states of 
the enzyme, E, F, and F' (Fig. 1-5) (1). Glutathione synthetase in a sub-
strate free condition, E, combines with ATP and y-Glu-Cys in the pres-
ence of Mg2+ to yield a ternary complex. This complex proceeds into the 
state F as the bound y-Glu-Cys is phosphorylated by ATP. 
ATP y-Glu-Cys Gly Pi GSH, ADP 
E -< t ~ >- F .. "1111(....!....~ ------L...t ~>- F' ~-<....&.....t -........ E t 
MTX 
FIG. 1-5. The proposed reaction mechanism of glutathione synthetase 
(Ref. I) and MTX inhibition. Glutathione synthetase in a substrate free state (E), 
a ternary complex with ATP and y-Glu-Cys (E'), a complex with phosphorylated y_ 
Glu-Cys (F), and a state in which glutathione is formed (F'). 
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The resulting phosphorylated y-Glu-Cys reacts with Gly to form a com-
plex in state F', from which ADP, Pi, and glutathione dissociate. Then, 
the enzyme returns to the initial state E. The types of inhibition by MTX 
summarized in Table I-Ill is consistent with this reaction scheme only 
when MTX binds to an ATP binding site of the E. coli B enzyme. In ad-
dition, inhibition by 7,8-dihydrofolate suggests that the ATP binding site 
is similar to a substrate binding site of dihydrofolate reductase. 
Here arises a question of whether the amino acid sequence similar-
ity found in this study was responsible for the binding of MTX to an ATP 
binding site of the E. coli B glutathione synthetase. This question is con-
sidered in the following discussion by analyzing crystal and gene struc-
tures of dihydrofolate reductases in relation to the similar portion of their 
amino acid sequences, because these structures of glutathione synthetase 
are unknown. Crystal structure of dihydrofolate reductase complexed 
with its ligands has been analyzed for the enzymes from L. casei, E. coli 
(30, 31), and chicken liver (32). Although amino acid sequences of dihy-
drofolate reductase are only 25 % identical between animal and bacterial 
enzymes, overall backbone chain folding of chicken liver dihydrofolate 
reductase is very similar to that observed in bacterial enzymes. About 70 
% of the additional residues present in the avian enzyme occur in three 
loops that were placed far from its substrate and cofactor binding sites. 
First, the interactions of the similar portion of the polypeptide 
chain of dihydrofolate reductase with MTX and NADPH are estimated by 
counting the number of amino acid residues involved in the binding of the 
ligands. The similar portion interacts with NADPH at the adenosine-. 
2',5'-diphosphate moiety and with MTX at the p-aminobenzamide moiety. 
Filman and Bolin et al (30, 31) have extensively studied the crystal struc-
ture of the ternary complex of the L. casei dihydrofolate reductase with 
NADPH and MTX. They listed the all amino acid residues that were con-
tact with the bound NADPH and ATP molecules. According to their list-
ing, eleven amino acid residues locate in contact with the adenosine 
diphosphate moiety of the bound NADPH molecule by van der Waals and 
hydrogen bonding interactions (30). Eight residues among them belong 
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to the similar portion (from Ile-38 to Val-75) of the polypeptide chain. 
Further more, among five amino acid residues which are involved in the 
binding of the p-aminobenzamide moiety of MTX (31), only three 
residues are present in the similar portion. Therefore, it is safely con-
cluded that the similar portion of the polypeptide chain in the L. casei di-
hydrofolate reductase interact with the binding of the adenosine diphos-
phate moiety of NADPH rather than with MTX. 
Secondary, the author analyzes the tertiary structure of the similar 
portion of the polypeptide chain of dihydrofolate reductase in terms of the 
correlation between the protein and gene structures of the enzyme. Ac-
cording to a molecular evolution theory of enzymes, functional domains 
in enzymes are related to the introniexon structure of the enzyme genes 
(33, 34). DNA sequences of mammalian genes of dihydrofolate reductase 
have been reported for mouse and human genes (35, 36, 37). The coding 
portions of the two genes are separated into six exons with identical exon 
boundaries at amino acid residues 30, 46, 81, 123, and 162. The similar 
portion of the amino acid sequence of the marrunalian dihydrofolate re-
ductases was from Gln-47 to Leu-89. This corresponds to the portion 
coded by exon 3 (from Gly-45 to Lys-80). Since the boundaries of se-
quence similarity is almost same to those of exon 3 in mammalian dihy-
drofolate reductases, the similar portion is a genetically distinct sequence. 
The correlation between the protein and gene structures of an en-
zyme has been analyzed by examining whether polypeptide chain coded by 
an exon (or exons) folds to make a structural unit distinct from other parts 
of the structure of the enzyme. For example, each ex on in hemoglobin 
and lysozyme has been correlated to a protein structure called 'module' 
(38, 39). This is visualized on a distance map, which is a plot of the dis-
tance between the i-th and j-th ex-carbon atoms in a triangular space (40). 
Protein folding of the L. casei dihydrofolate reductase is shown on a 
cex-cex distance map, along which six exons of the mouse gene are placed 
by aligning the amino acid sequence of the mouse enzyme to that of the L. 
casei enzyme (Fig. I-6). 
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FIG. 1-6. Distance map of a ternary complex of dihydrofolate reductase 
from L. casei with MTX and NADPH. The distances between the i-th and j-th 
a-carbon atoms were calculated from the crystal structure data in Protein Data Bank 
(Brookhaven National Laboratory, USA). Dark regions represented the pairs of a-car-
bon atoms separated by >25 A. Symbols N) and (H) are a-helix and 0-sheet 
structures, respectively. Five introns(Il-I5) and six exons (Exl-Ex6) are placed on the 
distance map by aligning the amino acid sequence of mammal dihydrofolate reductase 
with that of the L. casei enzyme. Dots are the boundary of similar sequence with glu-
tathione synthetase. The area A is the folding of the similar sequence. 
Dark regions represent the pairs of ca atoms separated by >25 A. Two 
large, dark regions in the distance map suggest that there are three struc-
tural segments divided from each other by introns 2 and 4. The segment 
constructed by the polypeptide chain coded by exons 3 and 4 is a distinct 
structural unit separated in space from the other two segments. In partic- . 
ular, distance between a pair of the Ca atoms in the polypeptide chain 
from Ile-38 to Val-75 is less than 25 A as shown in a triangular area A in 
Fig. 1-6. This part of the polypeptide chain is folded compactly. As to 
secondary structures of the enzyme, two ~-sheets and one a-helix are in-
cluded in the region coded by exon 3. The above analyses show that the 
polypeptide chain coded by exon 3 is best in the correlation between 
intron/exon and protein structures as well as in the sequence similarity 
with glutathione synthetase. From the above analyses, the similar portion 
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of the polypeptide chain in dihydrofolate reductase is defined as a distinct 
functional and structural unit that is responsible for the binding of 
NADPH. 
Thirdly, the author discusses the functional similarity between the 
NADPH binding site of dihydrofolate reductase and the ATP binding site 
of the E. coli B glutathione synthetase from the view of the chemical 
structures of ligands. Chemical structures of NADPH and ATP have a 
common substructure, adenosine phosphate moiety. The binding site of 
this substructure on the two enzymes might have similar affinity and 
specificity to other ligands. This is shown by the following observations. 
Stone and Morrison (41) have reported that 7,8-dihydrofolate caused 
substrate inhibition by binding to the NADPH binding site of dihydrofo-
late reductase. 7,8-Dihydrofolate could bind to this site because it has 2-
aminopteridine moiety that is a similar to adenosine moiety of NADPH. 
By the same way, 7,8-dihydrofolate and MTX are similar to ATP in their 
substructures, so they showed strong affinity to the ATP binding site of 
the E. coli B glutathione synthetase. NADPH molecule is too large in the 
size to fit the ATP binding site of the E. coli B enzyme (Table I-II). 
Therefore, the ATP binding site of the E. coli B enzyme is functionally 
resemble to the binding site of the adenosine diphosphate moiety of 
NADPH on dihydrofolate reductase, and must be constructed by the simi-
lar portion of the polypeptide chain. 
In conclusion, the author experimentally related the sequence simi-
larity found between two different types of enzymes to the similarity in 
their cofactor binding sites. The polypeptide chain from Arg-55 to Ile-96 
of the E. coli B glutathione synthetase, which is similar to dihydrofolate 
reductase, must be a genetically and structurally distinct subdomain re-
sponsible for the binding of ATP. The purpose of amino acid sequence 
similarity search is usually to get the best alignment of two sequences of 
proteins which have same physiological function but different in their 
origins. Similarity search between proteins with different biological 
functions, however, is a useful tool to discover their unknown functions 
and structural units. 
CHAPTER II 
Overexpression of the Escherichia coli B 
Glutathione Synthetase Gene, gsh II, and 
Rapid Purification of the Enzyme 
II-I INTRODUCTION 
A variety of strong promoters that are segment of DNA which direct 
RNA polymerase binding and initiation of transcription of a gene, have 
been developed and applied for construction of high-level expression 
plasm ids in E. coli (42). lac Promoter is a fusion of the consensus -35 
sequence from the tIp promoter and the consensus -10 sequence from the 
lac UV5 promoter (43, 44). Overexpression of prokaryote genes have 
been attained to 20 - 30 % of the total cell protein by subcloning down-
stream of the tac promoter (44, 45, 46, 47). 
In this Chapter, the author describes 1) construction of an overex-
pression plasmid for gsh II gene by use of pKK223-3 that contains a 
poly linker site flanked by the tac promoter and the rmB transcription 
tenninators (48); 2) kinetics and extent of induction, and stability of the 
plasmid; and 3) purification of the glutathione synthetase from E. coli 
cells containing the plasmid. 
II-2 EXPERIMENTAL PROCEDURES 
Bacterial Strains, Phages, and PJasmids Overexpression 
plasmid pKK223-3 containing the tacpromoter (43) was obtained from 
Pharmacia (Uppsala). Plasmid pGS400 is a pBR325 derivative containing 
a 1.8 kilobase pairs Bam HI fragment of glutathione synthetase gene from 
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E. coli B,gsh II (15). A host for pKK223-3 plasm ids and M 13 phages 
was E. coli JMI09 (rec A 1 end A I, gyrA 96, thi, hsdR 17, supE 44, 
relA 1, A-I, L1(Jac-proAB), [F, traD36, proAB, lad QZL1MI5]) (49). 
Chemicals Restriction enzymes, T4DNA ligase, and Klenow frag-
ment of DNA polymerase J were provided by TAKARA SHUZO 
CO.,LTD(Kyoto). ATP, NADPH and yeast glutathione reductase were 
purchased from Oriental Yeast Co.,(Tokyo). y-L-glutamyl-L-cysteine(y-
Glu-Cys) was supplied by Kojin Co.,(TokYo). DEAE-Cellulofine A-800, 
Cellulofine GCL-I 000 m were gifted from Chisso Co.,(Minamata). Iso-
propyl ~,D-thiogalactopyranoside(IPTG) was purchased from Nakalai 
Tesque Inc.(Kyoto). All other chemicals used were of the highest grade 
available. 
Construction of Overexpression Vectors Phage M 13mp8-
gshII, containing the wild-type entire gsh II gene, was cleaved at 
EcoOl09 site located 13 bases 3'-distal from Pribnow box of the gsh II 
gene and treated with Klenow fragment to repair end of the terminal, then 
cleaved at Pst I site (Fig. 11- I). The entire gsh II gene was isolated on 5% 
polyacrylamide gel electrophoresis and subcloned into Sma I and Pst I 
sites of pKK223-3. This derivative of pKK223-3 was designated 
pKGSOO. 
Growth of the cells and preparation of cell-free extracts E. 
coli cells were grown in the LB medium{l % tryptone, 0.5% yeast ex-
tract, and 1 % NaCO supplemented with 50 Jlglml ampicilline, the pH was 
adjusted to 7.5, at 37°C with reciprocal shaking. Culture were grown to 
nearly log phase (A,oo = 0.7 cm- I about 2.2 hr ), induced with IPTG (1 
rnM, final concentration), and then grown for 19 hours. Cells (from 500 
ml culture) were harvested by centrifugation at 10,000 x g for 10 min, 
washed with 50 ml of 20 mM Tris-HCl buffer, pH 7.3 containing 0.05 M 
NaCI and 5 mM MgCh, resuspended in 20 ml of the above buffer, and 
sonicated. The suspension was centrifuged at 15,000 x g for 20 min to 
remove cellular debris. 
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FIG. II-I. Construction of the overexpression vector of gsh II gene. Open 
bar arrowhead represents the tacpromoter and indicates the direction of transcription. 
The open bar represents the rrnB terminators. The solid bar represents the subdoned 
fragment of the gsh II gene. 
Purification of the glutathione synthetase All procedures were 
carried out at 0 - 4 dc. 
Step 1: DEAE-Cellulofine column chromatography Cell-free 
extract (20 ml, 380 mg protein) was applied to a DEAE-Cellulofine A-
800 column (2.4 x 48 cm) equilibrated with 20 mM Tris-HCI buffer,pH 
7.2 containing 5 mM MgCb and 50 mM NaCl. After washing the column 
with 500 ml of the same buffer, elution was carried out with a liner gradi-
ent of 0.05 - 0.3 M NaCl (0.5 I each in the mixing chamber and in the 
reservoir). The active enzyme was eluted at a NaCl concentration of 
approximately 0.15 M, and concentrated to about 5 ml on a Amicon PM-
10 membrane. 
Step 2: Cellulofine GeL-1000 chromatography The enzyme so-
lution from step 1 was applied to a Cellulofine GCL-IOOO m column (2.4 
x 96 ern) equilibrated with 50 mM potassium phosphate buffer, pH 6.8, 
containing 0.1 M NaCI and 5mM MgCh. Elution was carried out with the 
same buffer. The active fraction was concentrated on the Amicon mem-
brane and dialyzed against 50 mM potassium phosphate buffer, pH 6.8 
containing 5 mM MgCb. The enzyme preparation (I - 2 % concentration 
of protein) thus obtained was stored at 4 dc. 
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Enzyme activity assay The enzyme solution, 5 fJI, was added to an 
assay medium composed of 5 mM y-Glu-Cys, 15 mM Gly, 10 ruM ATP, 
10 ruM MgS04, and 100 ruM Tris-HCI buffer, pH 7.5, in a total volume of 
0.1 ml(50). Glutathione was determined as the amount of 2-nitro-5-
thiobenzoate anion which was formed by thiolysis of 5,5'-dithiobis(2-
nitrobenzoate) (DTNB) with glutathione in the presence of NADPH and 
glutathione reductase (I 7). One unit of enzyme was defined as the amount 
that catalyzed the formation of 1 fJmole of glutathione per min at 37°C. 
Protein assays Protein concentration of cell-free extract was mea-
sured by the method of Lowry et al. (19) with crystalline bovine serum 
albumin as the standard. The concentration of the glutathione synthetase 
in the purified preparation was determined from A~~o= 9.02 cm· 1 in 50 
mM potassium phosphate buffer, pH 7.0 (50). 
Polyacrylamide geJ electrophoresis Crude extracts as well as 
purified preparations were analyzed by 10 % SDS polyacrylamide gel 
electrophoresis according to the method of Laemmli (21). To determine 
the relative amount of the glutathione synthetase protein, the gels were 
stained with Coomassie Brilliant Blue R-250 and scanned at 570 om using 
a Model CS910 chromatoscanner (Shimadzu Co.). 
Amino-acid Analysis Amino-acid analysis was performed by fol-
lowing the method of Spackman et al. (51) with Hitachi model 835 amino-
acid analyzer. Sample of 2.8 n moles were hydrolyzed with 6 N HCI 
(constant boiling) in vacuo at 110 QC for 22 and 72 hours. Cysteine was 
determined as cysteinic acid after oxidation with performic acid (52). 
II-3 RESULTS 
Characterization of the expression of the gsh II in pKGSOO 
The Growth of E. coli JMI09 transformed with pKGSOO, a derivative 
of pKK223-3 containing the gsh II gene, and the induction of the expres-
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sian of the gsh II were shown in Fig. 11-2. In proportion to cell growth, 
glutathione synthetase specific activity increased to nearly 22.0 unitlmg in 
cell-free extract from 19 hr culture induced with IPTG. This activity was 
660-fold of that observed in chromosomal levels of the glutathione syn-
thetase specific activity (0.03 unit/mg) of E. coli 1M 1 09 in the absence of 
pKGSOO transformation. SOS-Polyacrylamide gel electrophoresis stained 
with Coomassie Brilliant Blue R-250 was used to measure the time course 
of glutathione synthetase protein synthesis in E. coli JM 109 containing 
pKGSOO induced with IPTG. Relative amounts of the glutathione syn-
thetase protein increased with specific activities and expression of gsh II 
on pKGSOO reached to a maximum of about 53 % of the total cellular 
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FIG. Il-2 Growth of the E. coli 1M I 09 transformed with pKGSOO, and 
the induction of the expression of the gsh II. Cells were grown in 500 ml of 
LB medium, containing 50 Ilg of ampicillin elm I, pH was adjusted to 7.5, at 37 Co with 
reciprocal shaking. After induction for 2.2 hour (A600 = 0.7cm·] ) at 37 CO IPTG (l 
mM, final concentration) was added to one of the culture but not the ~ther. At 
prescribed time intervals, 10 ml aliquots were withdrawn for preparation of cell-free 
extract and specific activities of glutathione synthetase were determined. After 19 h 
incubation with IPTG, The value of the specific activity was 22.0. This values has 
been assigned as 100, and the values for the other incubation times were related to that 
of it. For +IPTG : ~,growth; _, activity. For -IPTG : 0, growth; ., activity. 
Growth of the E. colI JMI09, not transformed was also examined and indicated by 
D., growth; ., activity. 
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FIG. II-3 SDS-PoJyacryJamide gel analysis of cell-free extract from in-
duced culture. E. coli 1M 109 transformed with pKGSOO were cultured and 
induced by IPTG as described in legend to Fig. II-2. Lanes 1 through 6 were grown 
for 1.5, 3, 5, 8, 12, 19 hours, respectively. Lane 7 was cell-free extract from E. coli 
1M 109 cells not transformed, were grown for 19 hours. E, glutathione synthetase; 
BPB, bromophenol blue. 
The expression of the gsh IT gene was also estimated from the comparison 
of specific activities between crude and purified preparations. 
Glutathione synthetase activities of the cell-free extract and purified 
preparation were 22.0 unitlmg and 42.8 unitlmg protein, respectively 
(Chapter I). Then, glutathione synthetase in the cell-free extract was 
estimated as about 51 % (=22.0+42.8 x 100) in purity based on its specific 
activity. 
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Thus, E. coli JM 109 cells transformed with overexpression 
plasm ids pKGSOO produced glutathione synthetase in active form at the 
expression level up to about a half of the cellular protein after induction 
with IPTG. However, no adverse effects of overexpression on cell 
growth was observed. 
Purification of the glutathione synthetase E. coli JM 1 09 
transformed by pKGSOO was cultured in 500 ml LB medium and har-
vested 17 hr after the IPTG induction. Cell-free extracts of E. coli 1M I 09 
were purified through DEAE-Cellulofine, then Cellulofine GCL-I 000 m 
column chromatography (Table II-I). One hundred and thirty-two mg of 
purified enzyme was finally obtained from 2.7 g of E. coli cells. The 
yield of activity in this procedure was about 65 %, and the purity of the 
enzyme was higher than 99 % as judged by SDS-polyacrylamide gel elec-
trophoresis (Fig. 11-4). 
TABLE II-I 
Purification of glutathione synthetase: Summary. 
Total Specific Total 
Recovery Purity 
protein activity activity 
(mg) (unita/mg) (unila) (%) ( -fold) 
Crude extract 380 22.0 8,360 100 
DEAE-Cellulofine 170 38.5 6,550 78.3 I. 75 
A-BOO 
Cellulofine 132 41.3 5,450 65.2 1.88 
GCL-IOOO m 
a One unit of enzyme was defined as the amount producing I ~ mole of GSH per min 
under standard assay condition. 
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FIG. II-4 SDS-Polyacrylamide gel analysis of enzyme purification. Lane 1, 
purified preparation by Celluloftne GCL-IOOO sf; lane 2, DEAE-Celluloftne A800 m 
fraction; lane 3, Cell-free extract. 
Amino-Acid AnaJysis of The Enzyme Amino-acid composition 
of the purified preparation was as follows (figures in parentheses are val-
ues expected from the base sequence of the gene): Ala 21.9(22), Arg 
19.2(19), Asp 31.3(32), Cys 4.0(4), Glu 39.0(38), Gly 25.3(25), His 
4.2(4), Ile 24.9(26), Leu 32.2(33), Lys 18.4(18), Met 9.9(10), Phe 
11.2(11), Pro 16.2(17), Tyr 9.0(9), Val 15.1(15). The agreement be-
tween these values and the values deduced from the nucleotide sequence 
was within 3 % of experimental error. 
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11 -4 DISCUSSION 
The author attained unusually higher overexpression of the gsh II gene up 
to 50% of the total cell-free protein by plasmid pKGSOO which was con-
structed by subcloning gsh II gene into a polylinker site downstream of tac 
promoter in plasmid pKK223-3. This plasmid pKGSOO is different in SD 
sequences from those pKK223-3 derivatives previously reported. That is, 
pKGSOO carries two SD sequences; the one is derived from the (3-galac-
tosidase gene downstream of the lac promoter and the other is from the 
gsh II gene (Fig. 11-5). Usually SD sequence is placed with an appropriate 
spacing before the initiation codon for efficient expression of a gene in E. 
coli. The translation efficiency is affected by the mRNAs secondary 
structure of ribosome binding site region (SD sequence) and the first sev-
eral tens bases downstream of the AUG start codon, because single-
strandedness of the SD sequence and protein start codon may be important 
for ribosome binding and the optimal translation (53, 54, 55, 56, 57, 58, 
59). In certain cases of poor expressions, these region makes a base-
paired stem and loop (hairpin) structure. The author analyzes several 
possible secondary structures of mRNA over 130 base length from 3'-
terminal to the start codon of gsh n gene by SOC-GENETYX(Software 
Development Co.) genetic information management software. Fig. IJ-6 
shows one of most probable secondary structure of mRNA at these re-
gions. It is indicated that the second SO sequence derived from gsh II 
gene, rather the first one from (3-galactosidase, is near the start codon and 
affect the translational efficiency. The second SD sequence (GAAG) is 
located neither in loop nor stem structure, but start codon AUG is posi- . 
tioned in a root of a little stem structure. However, this stem merely con-
tains a double-stranded region of 4 base-pairs and three of these are less 
stable A and T pairs. Consequently, the ribosome binding region between 
the second SD sequence and start codon of gsh II gene may form a single-
stranded state. Schottel et a1. suggested that base pairing of the region lo-
cated between the SD sequence and the AUG start codon, or of the start 
codon itself, did not substantially affect the efficiency of translation, 
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FIG 11-5. Nucleotide sequence of the region between the lac promoter and 
translational start codon of the gsh II gene in the plasmid, pKGSOO. The 
fusion point of the pKK223-3 vector DNA with the gsh II gene was indicated by 
arrow. -35, and -10 were -35 and -10 regions of the lac promoter. SD 1 and SD2 were 
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FIG 11·6. A possible mRNA secondary structure model for the region 
around the SD sequence and the start codon of the gsh II gene in the 
pKGSOO. Boxed areas indicated SD sequence and start codon AUG. 
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though the base pairing SD sequence with neighboring nucleotides reduces 
the translation efficiency (58). In addition, deBoer et al. suggested that 
the presence of the C and G residues following the SD sequence reduced 
the translation efficiency (60). The gsh II gene of pKGSOO has no C or G 
residues in the spacer between the SD sequence and the start codon (Fig. 
II~5, Fig. II~6). According to these reasons, pKGSOO exhibited the 
overexpression up to 50 % of the soluble cellular protein. 
Purification of the glutathione synthetase from E. coJiB previ-
ously took 4 steps and achieved with only 24 % yield of the crude extract 
in Chapter J. On the other, owing to this overproduction of the glu-
tathione synthetase by pKGSOO, a good yield (65%) has been attained by a 
simplified purification scheme (Table II-I) containing only 2 steps. This 
is necessary for the following experiments (Chapter III) examining the 
reactivity of mutant glutathione synthetases constructed by the site-
directed mutagenesis. 
CHAPTER III 
Role of Cysteine Residues in Glutathione 
Synthetase from Escherichia coli B 
Chemical Modification and Oligonucleotide 
Site-Directed Mutagenesis 
III-l INTRODUCTION 
It is essential for understanding the mechanism of enzymatic catalysis to 
identify the amino acid residues which comprise the active site of an en-
zyme and assign their specific roles. Escherichia coli B glutathione syn-
thetase is composed of four identical subunits; each subunit contains four 
cysteine residues (Cys-122, 195,222, and 289). Involvement of cysteine 
residues in the catalytic activity of glutathione synthetase has been sug-
gested from chemical modification using sulfhydryl reagents (1,4,6). 
One of preliminary experiments showed that DTNB was an in-
hibitor of the E. coli B enzyme as potent as pCMB and that only one mole 
of DTNB reacted with each subunit to induce complete inactivation of this 
enzyme. This suggests that among four cysteine residues present in a sub-
unit, only one sulfhydryl group is reactive with DTNB. 
In this study, the author has attempted to understand the structural 
and functional roles of the four sulfhydryl groups of the E. coli B glu-
tathione synthetase by giving answers to questions such as 1) which 
sulfhydryl group is reactive with DTNB, 2) whether other sulfhydryl 
reagents react with the same sulfhydryl group to DTNB reacts, and 3) 
whether these sulfhydryl groups are essential for catalytic activity. 
To identify the sulfhydryl group(s) reactive with sulfhydryl 
reagents, the author had to prepare at least four different mutant enzymes 
in which only one of four cysteine residues was abolished. A set of mutant 
genes, in which a codon of cysteine was replaced with that of alanine, were 
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constructed from the wild-type gsh II gene of E. coli B by site-directed 
mutagenesis. Other three mutant genes containing only two or no cysteine 
codons were also constructed. Each mutant of the gsh II gene was sub-
cloned into overexpression plasmid pKGSOO in which a mutant gene is 
controlled by the tac promoter (43) and inducible by IPTG. 
111-2 EXPERIMENTAL PROCEDURES 
Bacterial Strains. Phages, and PJasmids The plasmid pKGSOO 
was a overexpression plasmid for the glutathione synthetase gene (gsh II) 
of E. coli B. Construction of the pKGSOO has been described (in Chapter 
II) were as follows :Phage M 13mp8w-gshII, containing the wild-type en-
tire gshII gene, was cleaved at EcoOl09 site located 13 bases 3'-distal 
from Pribnow box of the gsh II gene and treated with Klenow fragment to 
repair end of the terminal, then cleaved at Pst I site. The entire gsh II 
gene was isolated on 5% polyacrylamide gel electrophoresis and 
subc10ned into Sma I and Pst I site of pKK223-3. Plasmid pGS400 is a 
pBR325 derivative containing a 1.8 kilobase pairs Bam HI fragment of 
glutathione synthetase from E. coli B, gsh II (15). M 13mp8w is a 
M13mp8 derivative lacking of amber mutation in genes I and II. Bacterial 
strains for oligonucleotide site-directed mutagenesis were E. coli JM 1 05 
(thi, rpsL, endA, sbcB 15, hspR 4, t1 (Jac -proAB), [F, lraD 36, proAB, 
lac/qZ, t1MI5]X49), and BW313(duf, ung, thi-I, relA, spoTl/FlysA). 
BW313 was a gift from Dr. Kagamiyama, Medical College of Osaka. A 
host for pKGSOO plasmids and M 13 phages was E. coli JM 109 (rec AI,. 
end AI, gyrA 96, thi, hsdR 17, supE 44, relA I, "A-I, ..1 (Iac-proAB ), [F, 
traD36, pro AB, lacI qz t1MI5])(49). 
Restriction Enzymes and Chemicals Restriction enzymes, 
T4DNA ligase, kinase, and Klenow fragment of DNA polymerase I were 
provided by TAKARA SHUZO CO.,LTD(Kyoto). Restriction enzyme 
Hga I was purchased from New England Biolabs (Beverly). Oligonu-
cleotides were synthesized by the solid phase phosphoramidite method(61) 
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and purified by high-performance liquid chromatography on Finepak SIL 
C18, (JASCO) or TSK-GEL DEAE-2SW, (TOYO SODA). Purified 
oligonucleotides were phosphorylated at 5' end with ATP and T4 DNA 
polynucleotide kinase. 
Chemicals used in this experiment were the purest grades commer-
cially available. 
Construction of Mutagenesis Vectors A 1817 base pairs 
Bam HI fragment encoding the entire gsh II gene was isolated from 
plasmid pGS400 and inserted into phage M13mp8w to give M13mp8w-
gshll (FIG. 111-1). This derivative was used as a single strand DNA 
template for mutagenesis of cysteine residues at 122, 195 and 289. DNA 
template for mutagenesis of cysteine residue at 289 was an M 13mp 18 
derivative containing a 449 base pairs Kpn II Bam HI small fragment of 
the gsh II gene. 
PvuD BamHI Hindm BamHI Hindlli PstI PvuD 
pGS400 L ____ l __ I ........ ' .... I __ l ___ J 
EcoRI BamHI Hindm 
I ' M13mp8w- _ _ _ : gshII . M1 C,22 095 C222 C289 Q31~ 1817bp ------11 
HpaJ AfiD Kpnl EcoRV BamHI PstJ 
I I !! I I ! : : : : 
M13 mp 18- ECORLII __ K~~.n.J ... f.c.OR.V. ___ ._B.a~ml_H_I-.JlstI 
gshDK/B t== 449bp . 
FIG. 111-1 Partial restriction maps of plasmid and phages. pGS400 is a 
pBR325(dotted line) derivative containing a 2.6 kilobase pairs Hind III fragment of gsh 
II gene(solid line). The internal Bam HI fragment (1817 base pairs) of pGS400 was 
ligated into the Bam HI polylinker site of M 13mp8w to yield M 13mp8w-gshII. The 
Kpn 1 and Bam HI fragment (449 base pairs) of gsh II gene was ligated into the 
Kpn I! Bam HI polylinker site of M 13mp 18 to yield M 13mp 18-gshIIKIB. 
34 Role of cysteine residues 
Site-Directed Mutagenesis by use of Uracil Containing SingJe-
Stranded DNA Oligonucleotide site-directed mutagenesis was per-
fonned by the method using uracil-containing single-stranded DNA as 
template (62). Single-stranded DNA template containing uracil was pre-
pared as follows (63). BW313 cells were grown overnight in 4 ml YT 
medium supplemented with 20 )lglml thymidine and 100 )lglml de-
oxyadenosine at 37°C with vigorous shaking. Two ml of the cultured 
cells were centrifuged (15 min at 2000 x g), washed with YT medium, re-
suspended in 100 ml of fresh 2 x YT medium pre-warmed to 37 ec, con-
taining 0.25 Jl glmI uridine, and shaken for 5 min. To this solution, 
Ml3mp8w-gshII phage were added at a multiplicity of infection of 5 and 
cultured for 5 hours at 37°C. Phage particles were collected and M 13 
single-stranded DNA template containing uracil was isolated (64). One 
pmole of the M 13 DNA template was annealed with 5 pmole of mis-
matched oligonucleotide in 20 IJI of Solution A(20 mM Tris-HCI, 10 mM 
MgCb, 50 mM NaCI, and 1 mM dithiothreitol, pH 7.5). After primer 
extension and ligation, the DNA was used to transform competent 1M 105 
cells. M 13 replicative form DNAs carrying the desired mutation were 
selected as follows. Each oligonucleotide used for the cysteine to alanine 
mutation was designed to create a new, appropriate site of restriction 
cleavage (or designed to abolish an existing site of restriction cleavage) 
adjacent to the amino acid replacement site (Table III-I). These sites of 
restriction cleavage were used for screening of M 13 DNAs for the desired 
mutations. Since the mutation of Cys-289 to Ala-289 does not introduce a 
new site of restriction cleavage for selection, a codon for Cys-289, TOT, 
was first mutated to TGA which creates an Eco RI site. This mutant was 
selected by screening with Eco RI. Then a codon TOA was changed to a 
codon of Ala by abolishing an Eco RI site. This mutant became silent to 
EeoRI. 
Short fragment containing the mutation site was excited from the 
alanine mutant of M 13mp8w-gshII DNA with two appropriate restriction 
enzymes, Hpa II Afl II fragment for the Ala 122 mutant, An III Kpn I for 
the Ala 195 mutant, and Kpn II Bam HI for the Ala289 mutants (Fig. 111- 1). 
This small fragment was subcloned into M 13mp 18 or M 13mp 19 at their 
cloning site for sequence analysis by dideoxy sequencing method (65). 
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TABLE 111-1 
Nucleotide sequences of synthetic oligonucleotide primers used for mutagenesis. 
Codon DNA sequence Enzyme 
Synthetic oligonucleotide#-
No. change for screening 
122 TGT-+ GCT S'-TCTCGTTAGCGTCGCGCA-3' HgaI 
195 TGC -+ GCC 5' -GCGCCA TG G CGTAGCGAG-3' Nco I 
222 TGC -+ GCC S'-GCGCCAGGGCGT ACGGTA-3' SpJ I 
289 TGT-+ TGA 5' -AA TCTCACGAA TTCAGGTTGGGCTG-3' EcoRI 
289 TGA- GCT 5'-AATCTCACGAATAGCGGTTGGGCTG-3' EcoRl 
aNucleotide substitutions are indicated with boldface and restriction sites created by 
mutation are underlined. 
After verified by the sequence analysis, a fragment containing the desired 
mutation was isolated on 5% polyacrylamide gel electrophoresis and 
transferred into overexpression vector pKK223-3. 
Expression of Wild and Mutant gsh II Genes E. coliJMI09 
cells transfonned with pKGSOO or one of the mutant plasmids were 
grown in 5 ml LB medium supplemented with 50 J..lglml ampicillin at 37°C 
with reciprocal shaking. At log phase (about ~oo = 0.7 cm- l ), IPTG was 
added to a final concentration of 1 mM (44). After 17 hour culture, the 
cells were harvested by centrifugation at 10,000 x g for 10 min, sus-
pended in 2 ml of 20 mM Tris-HCI buffer, pH 7.3, and sonicated. The 
suspension was centrifuged at 15,000 x g for 20 min to remove cellular 
debris and stored at -20 0c. Total concentration of proteins in a cell-free 
extract was detennined by the method of Lowry (19), with bovine serum 
albumin as standard. 
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Polyacrylamide Gel Electrophoresis CeIl-free extracts were 
analyzed by 10% SDS- and 7.5% native-polyacrylamide gel elec-
trophoresis according to the methods of Laemmli and Davis, respectively 
(21, 66). Authentic glutathione synthetase was a preparation purified 
from E. coli C600 (50). 
Determination of Glutathione Synthetase Activity Protein 
concentration of the glutathione synthetase was determined from 
A~~o=9.02 ern'! in 50 mM potassium phosphate buffer, pH 7.0 (50). The 
enzyme solution, 5 Ill, was added to an assay medium composed of 5 mM 
y-Glu-Cys, 15 mM Gly, 10 mM ATP, 10 mM MgS04, and 100 mM Tris-
HCl buffer, pH 7.5, in a total volume of 0.1 ml. Glutathione was de-
termined as the amount of TNB2- which was fonned by thiolysis of DTNB 
with glutathione in the presence of NADPH and glutathione reductase 
(17). One unit of enzyme was defined as the amount that catalyzed the 
formation of I Jlmole of glutathione per hour at 37°C. 
DTNB Titration of the Glutathione Synthetase Titration of 
sulfhydryl groups with DTNB was carried out according to the method of 
Ellman (67). Concentration of TNB2- was determined from molar ex-
tinction coefficient value, which was experimentally determined as 13,700 
cm-1 at 412 run. To determine the residual activities of the enzyme during 
the titration, 5 /.11 aliquots of the reaction mixture were added into the en-
zyme assay medium at intervals of 2 to 20 minutes. 
111-3 RESULTS 
Construction and Expression of Ala Mutant Glutathione Syn-
thetase Genes on Plasmid pKGSOO, derived from pKK223-3 
The author constructed seven mutant enzymes in which one or more 
cysteine residues were replaced with alanine residues. Ala 122, Ala 195, 
Ala222, and Ala289 are mutants containing a single replacement. In 
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AlaI22 mutant, for example, Cys-I22 residue is replaced with Ala-I22. 
Two mutants, Ala122/195 and Ala222!289, are those containing replace-
ment at two cysteine residues. A mutant in which all four cysteine 
residues are replaced is Cys-free mutant. 
AlaI22, Ala195, Ala222, and Ala289 mutants were made by site-
directed mutagenesis using synthetic oligonucleotides of between 17 and 
25 nucleotides in length, introducing either a single or double nucleotide 
substitution. Each mutation either introduced a new restriction site into 
the gene or deleted an existing one, and so these changes were used as 
markers to select the mutants. After confirmation of mutation by restric-
tion analysis of replicative form DNA and by dideoxy sequencing (65) of 
single stranded DNA, a restriction fragment containing a mutation site 
was excised from Ml3 replicative form DNA, then subcloned into 
pKGSOO by replacing the corresponding fragment of wild-type gene. 
Mutants containing multiple replacements at two or four cysteine 
residues were constructed by replacing a fragment containing a mutation. 
For example, Ala122/195 mutant gene was constructed by 1) restriction 
of AlaI22 mutant gene on pKGSOO plasmid with HincIVAfllI 2) delete of 
a fragment containing Cys-195 residue 3) insertion and ligation of the 
corresponding fragment containing Ala-195 residue restricted from 
Ala195 mutant gene. 
£. coli JM 109 transformed with overexpression plasmids contain-
ing one of Ala mutants of pKGSOO was cultured under the same conditions 
to that transformed with the wild-type pKGSOO. Cell-free extracts of E. 
coli JMI09 were prepared and analyzed by native polyacrylamide gel 
electrophoresis (Fig. 111-2). They showed a thick band on the gel at the 
almost same mobility to that of the authentic glutathione synthetase. 
Catalytic Activities of Mutant Glutathione Synthetases To 
estimate expression levels of mutant genes, cell-free extracts were 
submitted to SDS-polyacrylamide gel electrophoresis. The gels were 
stained with Coomassie brilliant blue R-250 and scanned by a chro-
matoscanner. Amounts of mutant glutathione synthetases, relative to the 
total protein in a cell-free extract, were about 50 % averaged over seven 
mutant enzymes. After correction with the relative amount of mutant 




FIG. ill-2. Native-polyacrylamide gel electrophoresis of the wild-type and 
mutant glutathione synthetases. E. colj JMI09 containing overexpression plas-
mid of wild-type and mutant gsh II genes were grown and induced by IPTG. Sample 
of each cell-free extract from 15 h induced culture were electrophoresed. Pure enzyme 
was also Nakalai as control. 
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glutathione synthetase present in cell-free extract, specific activities were 
determined for the mutant enzymes (Table III-II). From the specific ac-
tivities of Ala122, Ala195, Ala222, and Ala289 mutants, it was revealed 
that no critical loss in the activity was induced by the replacement of a sin-
gle cysteine residue with alanine residue. In Ala222 mutant, specific ac-
tivity increased to 150 % of the wild enzyme. These results, however, 
clearly indicated that four cysteine residues in the glutathione synthetase 
from E. coli B were not essential for the catalytic activity. Multiple re-
placement of cysteine residues, however, decreased enzymatic activity to 
45 - 26 % of the activity of the wild-type enzyme. Specific activity of 
mutant enzymes, Ala 122/19 5, Ala222/289, and Cys-free, decreased with 
the number of cysteine residues replaced. These results suggest that in the 
glutathione synthetase four cysteine residues, not a particular cysteine 
residue, evenly contribute to maintain its catalytic activity. 
TABLE III-II 
Enzyme activities of the wild-type and mutant glutathione synthetases. 
Apparent Expression Specific Relative 
specific activity level activity activity<: 
(uni~/mg) (0/0) (uni~/mg GSH-Ub) 
Wild-type 22.0 53 42 1.0 
Ala122 20.8 47 44 1.0 
Ala195 21.2 51 42 1.0 
Ala222 31.2 51 62 1.5 
Ala289 19.3 50 39 0.93 
AlaI211195 11.0 59 19 0.45 
Ala2221289 8.18 61 13 0.31 
Cys-free 3.40 31 11 0.26 
a 1 unit= 1 j..Irnol GSHlmin 
b mgGSH-I1=[Protein amount (mg)) x [Expression level (%YlOO} 
c The value for the specific activity of the wild-type enzyme has been assigned as 
1.0, and the values for the mutants are relative to that of the wild-type enzyme. 
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Titration of The Wild-Type Glutathione Synthetase with DTNB 
A solution of the purified glutathione synthetase (0.308mg protein in 
O.93ml 0.1 M phosphate buffer, pH 7.0 and O.lmM EDT A) was placed in a 
spectrophotometer cell and kept at 25°C. To this solution, 10mM DTNB 
20 J.d was added and mixed rapidly. Concentration of DTNB (200 11M) in 
the reaction mixture was 5.4-fold excess of the total concentration of 
sulfuydryl groups (37.2).1M sulfuydryl group). Concentration of TNB2. 
ion, which is released when DTNB reacts with sulfhydryl groups, 
increased rapidly in the first 10 min, then remained almost constant 
through 60 min. From the concentration ofTNB2. released for 60 min, 
the number of sulfuydryl groups titrated with DTNB was calculated and 
plotted against the time of reaction (Fig. 1II-3). About one mole of DTNB 
reacted with one mole of subunit of the glutathione synthetase; that is, 
among four sulfuydryl groups present in a subunit, only one sulfhydryl 
group reacted with DTNB. Time course of the loss of enzyme activity 
corresponded to the release ofTNB2~. Glutathione synthetase activity was 
rapidly decreased for the first 10 min then completely lost at 60 min by 
the reaction with DTNB. From this clear relation between the quantity of 
DTNB reacted and the degree of inhibition, it was shown that 
modification of one sulfhydryl group per subunit by DTNB resulted in the 
complete loss of the catalytic activity of the wild-type glutathione 
synthetase. 
Effects of Ligands on Inactivation by DTNB The wild-type 
enzyme (0.054 mg of enzyme protein in I ml 0.1 M phosphate buffer, pH 
7.0 containing 20 mM MgS04) was incubated with 10 mM each ligand and . 
0.1 mM DTNB at 25°C. The enzyme was protected from inactivation by 
y-glutamyl-L-a-aminobutyrate (y-Glu-Abu) and partially protected by 
ATP. y-Glu-Abu is an analogue of y-Glu-eys and Significantly active as y-
Glu-Cys (6)(Fig. 111-4). It was indicated that the modified cysteine was 
located at or near the active site of glutathione synthetase from E. coli. 
111-3. Results 





























o L-----L.--======::i:==~===~;t...,~ 0.0 ~ 
a 5 10 15 20 25 60 
Time (min) 
41 
FIG. III-3. Kinetics of DTNB modification of the wild-type glutathione 
synthetase_ Enzyme was incubated at 0.33 mg/ml with 0.2 mM DTNB in 0.1 M 
phosphate buffer (pH 7.0) at 25 0c. Increase in absorbance at 412 nm was recorded 
and aliquots(5 ~I) were withdrawn for determination of enzyme activity at appropriate 
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FIG. llI-4. Effects of ligands on Inactivation by DTNB. The wild-type en-
zyme( 0.054 mg/ml of glutathione synthetase protein) was incubated with 10 mM each 
ligand, 20 mM MgS04 , and 0.1 mM DTNB in 0.1 M phosphate buffer (pH 7.0) at 25 0c. Residual activities were determined at 5 and 10 min and shown as percent ratio to 
the activity at 0 min. Symbols associated with each experimental point were defined 
within the figure. 
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Inactivation of Mutant Glutathione Synthetases by DTNB 
Cell-free extracts containing Ala122, Ala195, Ala222, and 
Ala122!l95 mutant enzymes were inactivated at the wild-type rate in the 
first 10 min (Table III-III). Under the same experimental conditions, 
cell-free extracts containing Ala289, Ala222/289, and Cys-free mutant 
enzymes still retained their initial catalytic activity after 60 min of incu-
bation. These three mutant enzymes are insensitive to DTNB and lack a 
sulfhydryl group at the residue 289. With purified Ala289 mutant en-
zyme, only 0.07 mole per subunit ofTNB2- ion was observed after 60 min 
incubation with DTNB; that is, no DTNB reacted with Ala289 mutant. 
These results clearly show that Cys-289 is the only amino-acid 
residue reactive with DTNB in the glutathione synthetase and that modifi-
cation of Cys-289 residue with DTNB results in complete loss of the cat-
alytic activity. 
TABLE III-III 
Inactivation of the wild-type and mutant glutathione synthetases by DTNB. 
Each cell-free extract was incubated at 0.1 mg/m1 of glutathione synthetase 
protein with 0.1 mM DTNB in 0.1 M phosphate buffer (pH 7.0) at 25°C for 10 min. 
Residual activity was determined under the standard assay conditions, and shown as 
percent ratio to the activity at 0 min. 









111-3. Results 43 
Inactivation of Mutant Enzymes by NTCB Cell-free extracts 
containing mutant enzymes (0.1 mg enzyme protein in 1 ml of 0.1 M 
phosphate buffer pH 7.0) were incubated with 0.1 mM NTCB at 25°C for 
60 min. While cell-free extracts of Ala122, Ala195, Ala222, and 
Ala122/195 were inactivated at the same rate to the wild-type enzyme, 
those of Ala289, Ala222/289, and Cys-free mutants enzymes retained 
their catalytic activity (Fig. III-5). The latter three mutant enzymes have 
a replacement at Cys-289 residue with Ala-289. Thus, the target of NTCB 
























FIG. III-S. NTCB inactivation kinetics of the wild-type and mutant glu-
tathione synthetases. Each cell-free extract(O.l mg/ml of glutathione synthetase 
protein) was incubated with 0.1 mM NTCB in 0.1 M phosphate buffer (pH 7.0) at 
2SOC. Residual activities were detennined at 30 and 60 min and shown as percent ratio 
to the activity at 0 min. Symbols associated with each experimental point were defined 
within the figure. . 
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Inactivation of Mutant Enzymes by NEM Cell-free extract of 
each mutant enzyme (0.1 mg enzyme protein in 1 ml of 0.1 M phosphate 
buffer pH 7.0) was incubated with 0.3 mM NEM at 25°C. After 10 min 
incubation. the wild-type enzyme was inactivated only to 60 % of the ini-
tial activity. Ala195 mutant was inactivated at the wild-type rate. These 
findings indicate that NEM is not so potent an inhibitor as DTNB and 
NTCB of the wild-type glutathione synthetase. However, Ala122 and 
Ala122/195 mutant enzymes were inactivated by NEM to about 10 % of 
the initial activity (Fig. 111-6). NEM inactivated these two mutants at 
almost the same rate as DTNB. On the other hand, NEM failed to inacti-
vate Ala289. Ala222/289, and Cys-free mutant enzymes, in which Cys-
289 was replaced with Ala-289. From these results, NEM also modifies 
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FIG .. 1II.6. NEM inactivation kinetics of the wild-type and mutant glu-
tathl.one syn.thetases. ~ach cell·free extract(O. 1 mglml of glutathione synthetase 
pr~tetn) ~as lflcu~a~~d wIth 0.3 mM NEM in 0.1 M phosphate buffer (pH 7.0) at 
25 C. R~~dual aCtl~It\es were determined at 5 and 10 min and shown as percent ratio 
to. th~ acttvIty at 0 mm. Symbols associated with each experimental point were defined 
wIthm the figure. 
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Inactivation of Mutant Enzymes by pCMB Cell-free extracts of 
each mutant enzyme ( 0.1 mg enzyme protein in 1 ml of 0.1 M phosphate 
buffer pH 7.0) were incubated with 0.1 mM pCMB at 25°C. Ala122, 
Ala222, Ala289, and Ala222/289 mutant enzymes were inactivated at the 
same rate as the wild-type enzyme (Fig. 111-7). Unlike DTNB, NTCB, 
and NEM, pCMB inactivated mutants containing alanine in place of Cys-
289. Thus, the reactive site of pCMB is not the sulfhydryl group of Cys-
289. Ala195 mutant enzyme was less inactivated. Mutant enzymes, 
Ala122/195 and Cys-free were not inactivated by pCMB. Accordingly, 
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FIG. 111-7. pCMB inactivation kinetics of the wild-type and mutant glu-
tathione synthetases. Each cell-free extract(O.1 mglml of glutathione synthetase 
protein) was incubated with 0.1 mM pCMB in 0.1 M phosphate buffer (pH 7.0) at 
25°C. Residual activities were detennined at 2, 5, and 10 min and shown as percent 
ratio to the activity at 0 min; Symbols associated with each experimental point were 
defined within the figure. 
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111-4 DISCUSSION 
The author constructed seven Cys - Ala mutants of the E. coli B glu-
tathione synthetase and analyzed effects of the mutations on catalytic ac-
tivity and on inactivation by sulfhydryl reagents. When only one single 
cysteine residue in the E. coli B enzyme is replaced with alanine, each of 
four possible mutant enzymes Ala122, Ala195, Ala222, and Ala289 re-
tained almost the same catalytic activity to the wild-type enzyme. This 
clearly shows that anyone of the four sulfhydryl groups is not essential 
for the catalytic activity of the E. coJi B glutathione synthetase. 
Then, the inactivation of the enzyme by chemical modification of 
Cys-289 with sulfhydryl reagents is not due to the loss of chemical reac-
tivity of the sulfhydryl group of Cys-289. While the mutation of Cys-289 
to Ala-289 reduced the volume of the amino-acid side chain at residue 289 
from a sulfhydryl group to a less bulky hydrogen atom, chemical modifi-
cation introduces much bulkier group on the sulfhydryl group of Cys-289 
and increased the volume. The Wild-type enzyme was not inactivated by 
0.1 rnM DTNB in the presence of a substrate analogue, 10 mM y-glu-
tamyl-L-a-aminobutyrate. Presumably, Cys-289 of the E. coli B glu-
tathione synthetase is spatially close to substrate binding at the catalytic 
site. Chemical modification of Cys-289 would inhibit the access or bind-
ing of a substrate to catalytic site. Profy and Schimmel (68) constructed 
and studied about several eys - Ala mutants of glycyl-tRNA synthetase. 
Very similar to our present results, they found that a cysteine residue pre-
sumed essential from the inhibition experiments using NEM was not re-
quired for the catalysis of glycyl-tRNA synthetase. They also proposed 
that the inactivation of glycyl-tRNA synthetase by NEM was due to steric 
or conformational effects of the alkylated cysteine side chain by NEM. 
In addition, the author observed some perturbations in physico-
chemical properties on the E. coli B enzyme induced by the mutations of 
cysteines at residues 122 and 222. These two cysteine residues were in-
volved neither in catalytic reaction nor inactivation by three sulfhydryl 
reagents, but replacement of one of the two cysteines with alanine affected 
the reactivity of catalytic and inactivation reactions. The replacement of 
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Cys-122 with Ala-I22 enhanced the rate of inactivation with NTCB and 
NEM; that is, this replacement increased the reactivity of Cys~289 with 
NTCB and NEM. Mutation to Ala222 increased in both the catalytic ac-
tivity and the reactivity of Cys-289 with NEM. Further, on native poly-
acrylamide gel electrophoresis, mutants AlaI22 and Ala122!195 proteins 
were slightly different from those of the wild-type and the other mutants. 
Cysteines 122 and 222, not accessible by three sulfhydryl reagents, are 
probably located in inside of the enzyme. Any changes in volume of 
amino-acid side chains in this region are expected to induce some pertur-
bations in tertiary structure and/or charge distributions. These perturba-
tions were cumulative when more than two cysteine residues are replaced 
with alanine residues. Catalytic activities of AlaI22!195, Ala222/289, and 
Cys-free mutants dropped to 45 - 26 % of the wild-type enzyme. 
In conclusion, the present experiments unambiguously showed that 
four sulfhydryl reagents strictly differentiate between Cys-289 and Cys-
195 residues among four cysteine residues present in the E. coli B glu-
tathione synthetase. When site-directed mutagenesis of amino-acid 
residues is used in combination with various protein-modifying reagents, 
mutagenesis gives us precise informations about the mutual roles of the 
residues to maintain enzyme activity. 
CHAPTER IV 
Crystallization and Preliminary X-Ray 
Studies of Glutathione Synthetase 
from Escherichia coli B 
IV -1 INTRODUCTION 
X-ray crystallography showed us three-dimensional picture of several 
enzyme protein structures at atomic resolution. On the other hand, small 
angle X-ray scattering is a technique well suited for the determination of 
the overall size and shape of a protein in solution and for the characteriza-
tion of structural rearrangements that occur as a consequence of ligand 
binding. Furthennore, when atomic coordinates of a protein are avail-
able, scattering profiles computed from high resolution models based on 
the coordinates can be compared to experimental profiles to identify can-
didate solution structures. Comparisons of crystal and solution structures 
using small angle X-ray scattering have been reported for a number of 
enzymes, such as hen egg white lysozyme (69), yeast phosphoglycerate 
kinase (70), and horse liver alcohol dehydrogenase (71) and so forth. 
However, crystallographic analysis needs an appropriate protein crystals 
in substantial quantity, and consumes a large amount of purified protein 
for prediction of crystallization conditions. As described in Chapter II, 
the author already constructed overexpression plasmid pKGSOO, a 
derivative of pKK223-3 in which the gsh II gene is inserted behind the lac 
promoter and induction of E. coli 1M 109 cells containing pKGSOO with 
IPTG resulted in production of the enzyme as 53 % of soluble protein. 
From the resulting cell extract, glutathione synthetase was readily puri-
fied only 2 steps procedure as large amount as to need in crystallization 
experiments. 
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In this Chapter, the author describes the crystallization, prelimi-
nary crystallographic studies on the glutathione synthetase from E. coli B 
by X-ray diffraction, and also a small angle X-ray scattering measurement 
on the enzyme in aqueous solution. 
IV -2 EXPERIMENTAL PROCEDURES 
Materials Specially prepared ammonium sulfate, and IPTG were 
purchased from NACALAI TESQUE, INC.(Kyoto), DEAE-Cellulofine 
A800 from Chisso co. (Minamata). E. coli JMI09 containing pKGSOO 
was described before (72; Chapter II). 
Glutathione Synthetase Activity Protein concentration of the 
glutathione synthetase was determined from A~;oo = 9.02 cm-] in 50 mM 
potassium phosphate buffer, pH 7.0 (50). The enzyme solution, 5).11 was 
added to an assay medium composed of 5 mM y-Glu-Cys, 15 mM Gly, 10 
mM MgS04 , and 100 mM Tris-HCI buffer, pH 7.5, in a total volume of 
0.1 ml. GSH was determined as the amount ofTNB 2- which was fonned 
by thiolysis of DTNB with GSH in the presence of NADPH and glu-
tathione reductase (I 7). One unit of enzyme was defined as the amount 
that catalyzed the formation of 1 IJmole GSH per min at 37°C. 
Cell Growth and Purification of the Enzyme The E. coli 
1M 109 cells containing pKGSOO were grown in the 500 ml of LB medium 
(I % tryptone, 0.5% yeast extract, and 1 % NaCl) supplemented with 50 
)..lg/ml ampicillin, at pH 7.5, 37°C with reCiprocal shaking. At log phase 
(~oo = 0.7 cm· I , about 2.2 h), IPTG was added at the final concentration 
of 1 mM. After 17 hours, the cells were harvested by centrifugation ( 2.8 
g wet weight), suspended in 20 mM Tris-HCI buffer (pH 7.3) containing 5 
mM MgCb, and disrupted by sonication for 5 min. Cellar debris was re-
moved by centrifugation. Protein concentration of the extract (380 mg) 
was adjusted at 10 mg/ml, then finely powdered ammonium sulfate was 
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added to the extract as 35% saturation. After standing for 2 hours at 0 DC, 
microcrystals were appeared and collected by centrifugation at 10,000 x g 
for 15 min at 0 DC. These microcrystals were dissolved in 20 mM Tris 
HCl, pH 7.3 containing 5 mM MgCh and dialyzed against same buffer 
containing 5 mM MgCb and 0.1 M NaC!. The dialyzate was applied to a 
DEAE-Cellulofine A-800 column (2.4 x 33 em) equilibrated with the 
same buffer. After washing the column with 300 ml of the same buffer, 
the enzyme was eluted with 0.15 M NaCl in the buffer. The active frac-
tions (l51 mg protein) were collected and concentrated by ultrafiltration 
and dialyzed against 50 mM potassium phosphate buffer (pH 6.8) con-
taining 5 mM MgCb. The purity of the enzyme was estimated by elec-
trophoresis in the presence of sodium dodecyl sulfate (21). 
Crystallization Crystals were grown by vapor diffusion equilibra-
tion of 20 III drops hanging from siliconized microscope cover slips in-
verted on disposable plastic tissue culture plates (73) and by microdialysis 
methods using a 100 III siliconized cell, called "button"(Fig. IV -1) which 
was originally developed by Butler and Taylor (74). Protein solutions at a 
concentration of 5-30 mg/ml were prepared in the presence of 10-40 % 
saturated ammonium sulfate as precipitating agents in 50 mM potassium 
phosphate buffer ,containing 5 mM MgCb at pH range 5.5-6.8. The tem-
perature was controlled to keep at 25DC. 
X-Ray Diffraction Experiments Crystals were transferred to a 
40% saturated ammonium sulfate in 50 mM potassium phosphate buffer, 
pH 5.5 containing 5 mM MgCh, Crystals were mounted in thin-walled 
quartz capillaries and were photographed on a precession camera (Chales . 
Supper Co. Inc.) at 25 DC using nickel-filtrated Cu-Ka radiation from a 
Rigaku RU-200 rotating anode generator operated at 40 kV and 100 rnA. 
The crystal-to-film distance was set to 100 mm. Cell parameters were 
obtained using a Rigaku C-5 4-circle diffractometer at 10 DC. 
Small Angle X-Ray Scattering Experiments The experiments 
was performed according to Tanaka et al (75) and Morimoto (76). The 
X-ray source was a 0.4 x 8 mm spot on the copper anode of a Philips fine-
IV-2. Experimental procedures 
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FIG. IV-I. A plastic dialysis cell, for the growth of crystals in a volume 
of 0.1 ml. The sample is injected in the cells and is covered by a dialysis membrane 
secured by a piece of 0 ring, then the cel1 is placed in the outer solution in which ap-
propriate concentration of precipitate reagents are contained. 
focus X-ray tube, which was opened with a Rigaku D9C X-ray generator 
run at 40 kV, 36 rnA. Line focus was used to obtain sufficiently intense 
scattered X-rays. The spot was foreshortened to 0.04 x 8 mm at a glanc-
ing angle of 6°. The nickel-filtered (10 j.lm in thickness) X-rays were col-
limated with a 0.3 x 10 mm slit and then reflected and focused by a nickel-
coated glass mirror through two kinds of limiting slits (77) The sample 
solution was sucked into a thin walled quartz capillary tube (1.0 mm di-
ameter) by the injector through the tigon tube connected at the top of the 
capillary tube. The scattered X-rays were recorded on a one-dimensional 
position-sensitive proportional detector (delay-line type). The flowing 
gas (11 mm in thickness) used was a mixture of 90% argon and 10% 
methane. The width of the detector length was 50 mm and was divided 
into 512 channels on·a multichannel analyzer. The sample-to-detector 
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distance was 343.5 mm. The scattered X-rays were accumulated for 4000 
s in the range of the scattering angles from 3.0 x 10.3 to 7.7x 1 0. 2 rad. 
Each scattering intensity measurements were repeated 10 times. The X-
ray path from the sample holder to the detector was evacuated to avoid air 
scattering. The X-ray experiments were performed at 10°C. To avoid 
errors arising from interparticle interference, the scattering intensities 
were measured with four dilutions (3.0, 5.0, 8.0, and 12.0 mg of pro-
tein/ml in 50 mM potassium phosphate buffer, pH 6.8 containing 5 mM 
MgCh), and no difference in the scattering profiles was observed for the 
four dilutions. In order to correct the background X-ray scattering, the 
buffer solution was also measured. The scattering intensities recorded on 
both side of a primary beam were averaged at equivalent points after sub-
tracting background intensities. The center of the primary beam (zero 
angle) was precisely searched so as to realize the best coincidence of the 
scattering intensities at the equivalent points on both sides of the zero an-
gle. The coincidences expressed by a reliability factor Rsym (78) were 
good. The independent scattering intensity. 1(5), was then obtained by the 
deconvolution (desmearing) for beam height effect according to the 
method of Glatter (79). The scattering parameter, s , is defined by 5 = 
41ISin (J/)., where 2 (J is the scattering angle and A the wavelength of X-ray 
(A =1.5418 A). The radius of gyration, Rg , and zero-angle scattering 
profile, 1(0), were derived from Guinier plot (80) of the scattering 
intensity data by a least squares method. In the course of data analysis, the 
distance distribution function, p{r), was calculated by a Fourier trans-
form of the scattering profile (81). 
1 f"" P (r )=-2 I (5) ·sr ·sinsr . ds 
21T 0 
The maximum particle dimension, Dmax, was calculated from the dis-
tance, r, where p{r) finally vanishes. 
IV-3 RESULTS AND DISCUSSION 
Crystallization Crystals of glutathione synthetase shown in Fig. IV-
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2 were obtained as prisms (half-hexagonal) by vapor diffusion methods. 
The droplets consisted of 10 ~l of a pure enzyme solution containing 20 
mg protein/ml plus 1 0 ~l of a 27 % saturated (~)2S04 in 50 mM potas-
sium phosphate buffer, pH 5.5 containing 5 mM MgC12 and 0.04% NaN3. 
These droplets were equilibrated against 1 ml of 27% saturated ammo-
nium sulfate in 50 mM potassium phosphate buffer, pH 5.5 containing 5 
mM MgCh. After 2 days at room temperature, the crystals have dimen-
sion up to 0.3 x 0.2 x 0.1 rnm which were not large enough for X-ray 
diffraction studies. 
More large crystals of the enzyme were obtained by the micro 
dialysis methods (Fig. rV-3). One-hundred ~l of the protein solution 
containing 2 % glutathione synthetase, 20 % saturated (N}4)2S04, and 5 
mM MgCh in 50 mM potassium phosphate buffer (PH 5.5) was dialyzed 
against 30 ml of 27 % saturated (N}4)2S04, 5 mM MgCb, and 0.02 % 
NaN3 in the same buffer at 25°C. The large crystals (1.2 mm x 1.0 rnrn x 
0.4 mm) which could be subjected to X-ray diffraction studies were 
grown in a week. 
Fig. IV-2. Microphotograph of the glutathione synthetase crystals. Inner 
scale is 0.2 mm. 
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FIG. IV-3. Photograph of glutathione synthetase crystals in microdialysis 
cell. The large crystal is approximately 1.2xl.Ox0.4 mm. 
X-Ray Diffraction Studies X-Ray precession photographs indi-
cated that the crystals are hexagonal and belong to the Laue group, 6/ mmm. 
Fig. IV -4 shows a zero level precession photograph taken with the X-ray 
beam parallel to the 6-fold axis. The space group P6 222 or P 6422 
(indistinguishable crystallographically) are specified by the systematic 
absence of reflections 1=3n+ 1 and 1=3n+2 (Fig. IV -5). Dnit cell param-
eters are a=b = 88.0 A, c = 164.2 A, a =f3= 90°, and y= 120° which cor-
responds to a unit cell volume of 1.10 x 106 A3. On the assumption of one 
subunit per asymmetric unit, a y"1 value of 2.56 A3/dalton is calculated. 
This value is well within the range of 1.6 to 3.6 found to be typical for 
protein crystals (82). On the basis of a density for these crystals of 1.23 
glcm3 which was measured by a density-gradient system of CsCh the sol-
vent content of the unit cell is 46.6 %. The crystals diffract to at least 
2.5A resolution. X-ray diffraction data collections and search for heavy-
atom derivatives are in progress. 
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FIG. IV-4. Precession photograph of the bk 0 zone of the glutathione 
synthetase crystal. Precession angle, ).1= 15° (3.0 A resolution). 
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FIG. IV-S. Precession photograph of the b 01 zone of the glutathione 
synthetase crystal. Precession angle, ).1= 15° (3.0 A resolution). 
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Small Angle X-Ray Scattering Studies To obtain infonnation on 
the molecular shape of the enzyme, small angle X-ray scattering ex-
periments were carried out at 10 °C for four enzyme solutions with con-
centrations of 12, 8, 5, and 3 mglml in 50 mM phosphate buffer, pH 6.8 
containing 5 mM MgCh. The radius of gyration of the enzyme molecule 
was found to be 35.0 A from the Guinier plot (Fig. IV -6) and the distance 
distribution function p(r) (Fig. IV -7). Since the respective plots in Fig. 
VJ-6 are parallel to one another, it can be considered that the influence of 
the protein concentration at the scattering intensities is negligibly small 
under these conditions. The maximal dimension of the molecule was es-
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FIG. 1V:6. Guinier plots of the small angle X-ray scattering intensities of 
glutathIone synth~t~se. The enzyme was dissolved in 50 mM potassium phosphate 
buffer, pH 6.8 contamlng 5 mM MgCI2. The values of concentration of the enzyme 
were defined within the figure. 
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FIG. IV -7. Distance distribution functions P (r) for glutathione syn-
thetase. Protein concentmtion was 3.0 mglml. 
The volume of the enzyme molecule calculated from Porod's invariant 
and the scattered intensity at zero angle (83) was 2.28 x 105 A3, which was 
larger than the 1. 93 x 105 A 3 in the crystalline state, because of the 
hydration effect with the enzyme molecule in the aqueous solution. The 
molecular weight estimated from the volume (84) was 140,000, which 
agreed with those obtained by other methods (7). Such information on the 
molecular shape obtained by small angle X-ray scattering techniques 
should be useful to isolate each molecule on an electron density map on the 
crystal structure analysis. 
GENERAL CONCLUSION 
Glutathione synthetase (EC 6.3.2.3) from Escherichia coli B 
showed amino acid sequence similarity with mammalian and bacterial di-
hydrofolate reductases over 40 residues, although these two enzymes are 
different in their reaction mechanisms and ligand requirements. Thus the 
effects of ligands of dihydrofolate reductase on the reaction of E. coli B 
glutathione synthetase were examined to fmd resemblances in catalytic 
function to dihydrofolate reductase. Consequently, it was found that the 
E. coliB enzyme was potently inhibited by 7,8-dihydrofolate, metho-
trexate, and trimethoprim. From more detailed studies, methotrexate was 
proved to bind to an ATP binding site of the E. coli B enzyme with K j 
value of 0.1 mM. In addition, the similar portion of the amino acid 
sequence in dihydrofolate reductases, which corresponded to the portion 
coded by exon 3 of mammalian dihydrofolate reductase genes, are known 
to provide a binding site of the adenosine diphosphate moiety of NADPH 
in the crystal structure of dihydrofolate reductase. These analyses would 
indicate that the similar portion of the amino acid sequence of the E. coli 
B enzyme proVides the ATP binding site. This is the first experimental 
evidence that amino acid sequences related by sequence similarity 
conserve functional similarity even in enzymes being different in their 
catalytic mechanisms. 
The overexpression plasmid, pKGSOO, in which the glutathione 
synthetase gene from E. coli B (gsh II) was controlled by tac promoter 
and rm B terminator, was constructed. The kinetics and extent of induc-
tion in E. coli 1M 1 09 showed that after 17 hr of induction (total 19 hr 
culture), the glutathione synthetase in active form constituted about 53 % 
of the total soluble protein of E. coli cells. The specific activity of the 
cell· free extract from the cells transformed with pKGSOO was 660-fold of 
that observed in chromosomal levels of E. coli JMI09. From 500 m! of 
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culture, two purification procedures gave 130 mg of a purified enzyme 
preparation. 
E. coli B glutathione synthetase is composed of four identical sub-
units; each subunit contains four cysteine residues (Cys-122, 195, 222, and 
289). Then, the author constructed seven different mutant enzymes con-
taining three, two, or no cysteine residues per subunit by replacement of 
cysteine codons with those of alanine in the gsh II gene using site-di-
rected mutagenesis. Among of them, three mutant enzymes Ala289, 
Ala2221289, Cys-free(AlaI22/195/2221289), in which cysteine at residue 
289 was replaced with alanine, were not inactivated by 5,5'-dithiobis-(2-
nitrobenzoate) (DTNB), while the other four mutants retaining Cys-289 
were inactivated at the wild-type rate. From these selective inactivations 
of mutant enzymes by DTNB, the sulfhydryl group modified by DTNB 
was unambiguously identified as Cys-289. In this way, Cys-289 was 
found to be also a target of modification with 2-nitrothiocyanobenzoate 
(NTCB) and N-ethylmaleimide (NEM), while Cys-195 was of p-
chloromercuribenzoate (pCMB). These results suggest that both Cys-195 
and Cys-289 were not essential for the activity of the glutathione 
synthetase, but chemical modification of either one of the two sulfhydryl 
groups resulted in complete loss of the activity. Replacement ofCys-122 
to Ala-I 22 enhanced the reactivity of Cys-289 with sulfhydryl reagents. 
Preliminary X-ray studies on E. coli B glutathione synthetase have 
been carried out using crystallographic and small angle scattering tech-
niques. The glutathione synthetase from E. coli B was crystallized to 
suitable for X-ray analysis. It is the first time to succeed in the crystal-
lization of glutathione synthetase. The crystals are hexagonal, space 
group P 6222 or P 6422 (indistinguishable crystallographically). Th e 
cell dimensions are a= b= 87.8 A, c= 163.9 A, a= {3= 900 , and y=120°. 
The enzyme is a tetramer of Mr 143,000, and the asymmetric unit con-
tains one subunit molecule of M r 35,600. The crystals diffracted to at 
least 2.5 A resolution. A small angle X-ray scattering study showed that 
the radius of gyration and the maximal dimension of the tetramer 
molecule in aqueous·solution are 35.0 A and 100 A, respectively. 
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